Despite bans on elective orthopedic procedures, large device companies have successfully pivoted to weather the COVID-19 pandemic.
The Latest
BlueCross BlueShield of Texas on April 27 recognized DHR Health as a Blue Distinction Center+ for spine surgery and a Blue Distinction Center for knee and hip surgeries, the Progress Times reports.
The FDA on April 28 granted Life Spine 510(k) clearance to market implant and instrument additions to its ARx spinal system.
Taylor Cera, COO of Orthopaedic Surgery Center in Youngstown, Ohio, outlines how the surgery center plans to ramp up elective surgeries and recover from the COVID-19 pandemic.
Anika Therapeutics made its interim CEO and president Cheryl Blanchard, PhD, permanent April 26, the company announced.
Oren Gottfried, MD, is professor of neurosurgery and clinical vice chair of quality in the department of neurosurgery at Duke University School of Medicine in Durham, N.C. He is also past-president of the North Carolina Spine Society,
Aurora Spine, a Toronto, Canada-based spinal implant manufacturer, on April 27 received loan proceeds of $450,877 under the Paycheck Protection Program, as part of the Coronavirus Aid, Relief and Economic Security Act.
CMS has suspended advance Medicare payments to Part B suppliers, including physicians, other medical professionals and durable medical equipment suppliers, and is reevaluating accelerated payments to hospitals.
Medtronic Executive Chairman Omar Ishrak recently appeared on CNBC's "Squawk on the Street" to discuss COVID-19 and resuming medical procedures for non-urgent, non-COVID-19 patients.
Stryker reported executive pay reductions in an SEC filing on April 27 due to the pandemic.